This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08299/identifier/pdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08299/identifier/pubchem-compound/
n7http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB08299/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n14http://linked.opendata.cz/resource/drugbank/drug/DB08299/identifier/drugbank/
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n4http://linked.opendata.cz/ontology/drugbank/
n5http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB08299/identifier/chemspider/

Statements

Subject Item
n2:DB08299
rdf:type
n4:Drug
n4:group
experimental
owl:sameAs
n7:DB08299 n10:DB08299
dcterms:title
4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid
adms:identifier
n9:99444770 n11:NPV n12:9999276 n13:8174857 n14:DB08299
n4:IUPAC-Name
n5:271B4A9D-363D-11E5-9242-09173F13E4C5
n4:InChI
n5:271B4AA3-363D-11E5-9242-09173F13E4C5
n4:Molecular-Formula
n5:271B4AA2-363D-11E5-9242-09173F13E4C5
n4:Molecular-Weight
n5:271B4A9F-363D-11E5-9242-09173F13E4C5
n4:Monoisotopic-Weight
n5:271B4AA0-363D-11E5-9242-09173F13E4C5
n4:SMILES
n5:271B4AA1-363D-11E5-9242-09173F13E4C5
n4:Water-Solubility
n5:271B4A9B-363D-11E5-9242-09173F13E4C5
n4:logP
n5:271B4A9C-363D-11E5-9242-09173F13E4C5 n5:271B4A99-363D-11E5-9242-09173F13E4C5
n4:logS
n5:271B4A9A-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Acceptor-Count
n5:271B4AA9-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Donor-Count
n5:271B4AAA-363D-11E5-9242-09173F13E4C5
n4:InChIKey
n5:271B4AA4-363D-11E5-9242-09173F13E4C5
n4:Polar-Surface-Area--PSA-
n5:271B4AA5-363D-11E5-9242-09173F13E4C5
n4:Polarizability
n5:271B4AA7-363D-11E5-9242-09173F13E4C5
n4:Refractivity
n5:271B4AA6-363D-11E5-9242-09173F13E4C5
n4:Rotatable-Bond-Count
n5:271B4AA8-363D-11E5-9242-09173F13E4C5
n4:Bioavailability
n5:271B4AAF-363D-11E5-9242-09173F13E4C5
n4:Ghose-Filter
n5:271B4AB1-363D-11E5-9242-09173F13E4C5
n4:MDDR-Like-Rule
n5:271B4AB2-363D-11E5-9242-09173F13E4C5
n4:Number-of-Rings
n5:271B4AAE-363D-11E5-9242-09173F13E4C5
n4:Physiological-Charge
n5:271B4AAD-363D-11E5-9242-09173F13E4C5
n4:Rule-of-Five
n5:271B4AB0-363D-11E5-9242-09173F13E4C5
n4:Traditional-IUPAC-Name
n5:271B4A9E-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-acidic-
n5:271B4AAB-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-basic-
n5:271B4AAC-363D-11E5-9242-09173F13E4C5